Epidermal growth factor receptor and insulin-like growth factor-I receptor expression and function in human soft-tissue sarcoma cells

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 329-336

  Beech, Derrick ^a,b   Pollock, Raphael E ^a   Tsan, Rachel ^a   Radinsky, Robert ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Growth factor receptors; Human soft tissue sarcoma; Metastasis; Molecular determinants; Signal transduction; Therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROTEIN P53; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHONDROSARCOMA; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG METASTASIS; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

EID: 0031909380     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.329     Document Type: Article

References (29)

1. Wingo PA, Tong T and Bolden S: Cancer statistics. Cancer J Clinicians 45: 8-30, 1995.
2. Beech DJ and Pollock RE: Surgical management of primary soft tissue sarcoma. Hcmatol Oncol Clin N Amer 9: 707-718, 1995.
3. Pollock RE: Molecular determinants of soft tissue sarcoma proliferation. Semin Surg Oncol 10: 315-322, 1994.
4. Cooper CS: The molecular and genetic characterization of human soft tissue tumors. Adv Cancer Res 60: 75-120, 1993.
5. Sreekantaiah C, Ladanyi M, Rodriguez E, and Chaganti RSK: Chromosomal aberrations in soft tissue tumors. Am J Pathol 144:1121-1134, 1994.
6. Shin DM, Gupta V, Donner L, Chawla S, Benjamin R, Gutterman J and Blick M: Aberrant oncogene expression in uncultured human sarcoma and melanoma. Anticancer Res 7: 1117-1124, 1987.
7. Perosio PM and Brooks JJ: Expression of growth factors and growth factor receptors in soft tissue tumors. Lab Invest 60: 245-253, 1989.
8. Gusterson B, Cowley G, McIhinney J, Ozanne B, Fisher C and Reeves B: Evidence for increased epidermal growth factor receptors in human sarcomas. Int J Cancer 36: 689-693, 1985.
9. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD and Bar-Eli M: Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild-type p53. Oncogene 9: 1877-1883, 1994.
10. Pollock RE, Lang A, Luo J, El-Naggar AK and Yu D: Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Oncogene 12: 2035-2039, 1996.
11. Pollock RE, Lang A, El-Naggar AK, Radinsky R and Hung MC: Enhanced MDM2 oncoprotein expression in soft tissue sarcoma: several possible regulatory mechanisms. Sarcoma 1: 23-29, 1997.
12. El-Naggar AK, Barlogie B, McCabe K, Teague K, Ensign LG, and Pollock RE: Acridine orange DNA/RNA content analysis of soft-tissue tumors: correlation with clinicopathologic factors and biological behavior. CMB 1: 237-247, 1994.
13. Hu M, Pollock RE, Nakamura T and Nicolson GL: Human peritumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains. Int J Cancer 62: 585-592, 1995.
14. 2-terminal fragment of human fibronectin. Cancer Res 57: 3577-3584, 1997.
15. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD and Fidler IJ: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1: 19-31, 1995.
16. Singh RK, Tsan R and Radinsky R: Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin Exp Metastasis 15: 140-150, 1996.
17. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992.
18. Dean M, O'Connell P, Leppert M, Park M, Amos JA, Phillips DG, White R and van de Woode GF: Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediat R 111: 490-495, 1987.
19. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Jeanteur P and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatedehydrogenase multigenic family. Nucleic Acids Res 13: 1431-1442,1985.
20. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
21. Alley MC, Scudiero DA, Monks A, Hursey ML, Czcrwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988.
22. -. Revertant 3T3 cells on fibronectin proteolytic fragments. Cancer Res 50: 4388-4400, 1990.
23. Wu X, Bayle JH, Olson D and Levine AJ: The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132, 1993.
24. Otto A and Deppert W: Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53. Oncogene 8: 2591-2603, 1993.
25. Radinsky R: Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev 14: 323-338, 1995.
26. Kappel CC, Velez-Yanguas MC, Hirscfeld S and Helman LJ: Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54: 2803-2807, 1994.
27. Roholl PJ, Skottner A, Prinsen I, Lips CJ, den Otter V and van Unnik JA: Expression of insulin-like growth factor 1 in sarcomas. Histopathology 15: 455-460, 1990.
28. Deuel TF and Huang JS: Roles of growth factor activities in oncogenesis. Blood 64:951-958, 1984.
29. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R and Baserga R: A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14: 4588-4595, 1994.